NANO MRNA Co.,Ltd.JP:4571
| Mar 31,
2013 | Mar 31,
2014 | Mar 31,
2015 | Mar 31,
2016 | Mar 31,
2017 | Mar 31,
2018 | Mar 31,
2019 | Mar 31,
2020 | Mar 31,
2021 | Mar 31,
2022 | Mar 31,
2023 | Mar 31,
2024 |
|---|
| Profit (loss) before income taxes | -482 | -1,111 | -206 | -2,534 | -2,672 | -5,413 | -1,805 | -2,006 | -2,832 | -1,879 | -1,308 | -778 |
|---|
| Depreciation | 7 | 5 | 19 | 28 | 21 | 26 | 9 | 1 | 2 | 3 | 0 | 1 |
|---|
| Interest income | -4 | -18 | -28 | -51 | -43 | -26 | -13 | -16 | -14 | -13 | -25 | -26 |
|---|
| Foreign exchange losses (gains) | -102 | -222 | -919 | 361 | 31 | 35 | -35 | 10 | -19 | -77 | -59 | -54 |
|---|
| Share-based payment expenses | 28 | 12 | 48 | 50 | 3 | - | - | - | 5 | 16 | 25 | 42 |
|---|
| Subsidy income | - | - | - | - | - | - | - | - | - | - | -70 | -46 |
|---|
| Share issuance costs | 10 | 211 | 8 | 0 | 3 | 0 | 17 | 33 | 1 | 0 | 0 | 0 |
|---|
| Subscription rights to shares issuance cost | 1 | 4 | 3 | 13 | - | - | 6 | 9 | - | 5 | - | 10 |
|---|
| Gain on reversal of share acquisition rights | - | - | - | - | -9 | -33 | -23 | -2 | - | -56 | -27 | - |
|---|
| Profit on redemption of bonds | - | - | - | - | - | - | - | - | - | - | -39 | - |
|---|
| Loss (gain) on sale and retirement of non-current assets | - | 0 | 1 | 0 | 0 | 0 | 0 | - | - | - | -4 | -1 |
|---|
| Gain on sale of investment securities | - | - | - | - | - | - | - | - | - | - | - | -42 |
|---|
| Loss on valuation of investomet securities | - | - | - | - | - | - | - | - | - | - | 268 | - |
|---|
| Impairment losses | 50 | 16 | 34 | 153 | 62 | 141 | 53 | 4 | 1,553 | 15 | 7 | 71 |
|---|
| Decrease (increase) in trade receivables | -4 | -22 | -209 | 135 | 36 | -26 | -101 | 69 | 78 | -12 | 20 | 7 |
|---|
| Decrease (increase) in advance payments to suppliers | - | - | - | - | - | - | -57 | -71 | -29 | 57 | 6 | 28 |
|---|
| Decrease (increase) in inventories | -82 | -22 | 151 | -98 | -126 | 124 | 119 | -43 | -62 | 105 | 33 | 0 |
|---|
| Increase (decrease) in trade payables | - | - | - | - | - | - | - | - | - | - | 4 | -6 |
|---|
| Increase (decrease) in accounts payable - other | -3 | 22 | 31 | 68 | 100 | -113 | -38 | -40 | 24 | 2 | -78 | 25 |
|---|
| Increase (decrease) in deposits received | 0 | -4 | 1 | 1 | 3 | 1 | -2 | -4 | -2 | -0 | 140 | 87 |
|---|
| Other, net | -37 | 40 | -4 | 3 | 14 | -1 | -56 | 48 | 23 | 62 | 48 | 71 |
|---|
| Subtotal | -637 | -1,098 | -1,143 | -2,024 | -2,595 | -4,965 | -2,050 | -1,150 | -1,255 | -1,760 | -1,154 | -610 |
|---|
| Interest received | 4 | 14 | 24 | 54 | 73 | 41 | 16 | 15 | 11 | 10 | 19 | 28 |
|---|
| Subsidies received | - | - | - | - | - | - | - | - | - | - | 50 | 0 |
|---|
| Income taxes paid | -2 | -2 | -2 | -2 | -3 | -4 | -4 | -4 | -4 | -4 | -2 | -2 |
|---|
| Net cash provided by (used in) operating activities | -635 | -1,087 | -1,121 | -1,971 | -2,526 | -4,928 | -2,037 | -1,139 | -1,247 | -1,753 | -1,087 | -585 |
|---|
| Payments into time deposits | -1,701 | -8,892 | -8,701 | -7,143 | -2,010 | -1,601 | -2,708 | -1,706 | -2,914 | -2,655 | -1,502 | -1,502 |
|---|
| Proceeds from withdrawal of time deposits | 1,700 | 1,958 | 6,417 | 16,955 | 1,736 | 2,604 | 2,207 | 2,702 | 1,426 | 2,227 | 2,448 | 2,502 |
|---|
| Purchase of securities | - | - | - | -1,000 | -5,200 | -9,035 | -9,400 | -7,500 | -11,800 | -10,600 | -6,240 | -5,800 |
|---|
| Proceeds from redemption of securities | - | - | - | - | 5,167 | 8,669 | 10,132 | 6,500 | 12,400 | 10,710 | 7,000 | 5,738 |
|---|
| Purchase of investment securities | - | -98 | - | -1,335 | -113 | -359 | -1,216 | -108 | - | -10 | -500 | -200 |
|---|
| Proceeds from sale of investment securities | - | - | - | - | - | - | - | 14 | - | 73 | - | 140 |
|---|
| Payments of leasehold and guarantee deposits | - | - | -13 | -3 | - | - | - | - | - | -4 | - | -32 |
|---|
| Proceeds from refund of leasehold and guarantee deposits | - | - | 5 | - | - | - | - | - | 2 | 22 | - | 12 |
|---|
| Other, net | - | -0 | - | - | - | - | - | -14 | 13 | -2 | 2 | -65 |
|---|
| Net cash provided by (used in) investing activities | -121 | -7,059 | -2,562 | 7,385 | -597 | 215 | -992 | -112 | -872 | -244 | 1,208 | 793 |
|---|
| Proceeds from issuance of share acquisition rights | - | 1 | 7 | 98 | - | - | 30 | - | - | - | - | 4 |
|---|
| Purchase of treasury shares | - | - | - | - | -0 | - | - | - | - | - | - | - |
|---|
| Net cash provided by (used in) financing activities | 2,327 | 9,581 | 505 | 3,101 | 88 | 24 | 3,385 | 2,162 | -11 | 1,146 | - | 4 |
|---|
| Effect of exchange rate change on cash and cash equivalents | 102 | 145 | 197 | -117 | -30 | -8 | 22 | -5 | 5 | 57 | 59 | 54 |
|---|
| Net increase (decrease) in cash and cash equivalents | 1,673 | 1,580 | -2,982 | 8,398 | -3,064 | -4,697 | 377 | 905 | -2,126 | -795 | 180 | 266 |
|---|
| Increase in cash and cash equivalents resulting from inclusion of subsidiaries in consolidation | - | - | - | - | - | - | - | - | - | - | 32 | - |
|---|